Jill Steier | Executive Director, Investor Relations and Corporate Communications |
Mark Iwicki | Chairman, President and Chief Executive Officer |
Kim Brazzell | Chief Medical Officer |
Todd Bazemore | Chief Operating Officer |
Mary Reumuth | Chief Financial Officer |
Andreas Argyrides | Wedbush |
Christopher Neyor | JPMorgan |
François Brisebois | Oppenheimer |
Chris Howerton | Jefferies |
Good morning, and welcome to Kala Pharmaceuticals Conference Call to review its Third Quarter Financial Results and the Acquisition of Combangio. Please note that the slide presentation that was designed to accompany this conference call is available on Kala's website, kalarx.com, as well as through the webcast player. At this time all participants are in a listen-only mode.
Following management's prepared remarks, the Q&A session will be held.
As a reminder, this call is being recorded.